Editorial

Compensation for research injuries: Thoughts from a human research ethics committee chair

Peter Cleaton-Jones

Abstract


In the first clinical trial compensation court case in South Africa (Venter vs Roche Products (Pty) Limited and Others (case no. 12285/08), Association of the British Pharmaceutical Industry guidelines compensation limited a participant to appropriate medical treatment, which is common in many countries. Change in policy is likely to take years, but what could be done rapidly for potential clinical trial participants is to make the limitation more obvious by placing this in a separate page instead of in a small section near the end of multipage information and consent document.

Author's affiliations

Peter Cleaton-Jones, Chair, Human Research Ethics Committee (Medical), University of the Witwatersrand, Johannesburg, South Africa

Full Text

PDF (544KB) HTML

Keywords

Research-related injury; Compensation

Cite this article

South African Medical Journal 2014;104(11):755-756. DOI:10.7196/SAMJ.8939

Article History

Date submitted: 2014-09-20
Date published: 2014-09-20

Article Views

Abstract views: 2117
Full text views: 3484

Comments on this article

*Read our policy for posting comments here